Late Breaking Abstract - Exploring optimal management of mild to moderate long-COVID symptoms with OTC medication
Bibliographic record
Abstract
Background: Long COVID (LC) refers to the sequel or development of new symptoms 3 months after initial COVID-19 infection, affecting more than 17 million people across the WHO European Region. Understanding use of over-the-counter (OTC) medication in LC is crucial due to its global impact and real-world use. Aims and Objective: The review aims to guide clinicians in understanding and managing LC symptoms using OTC medication. Method: A literature search was conducted upto May 27, 2024 in PubMed & EMBASE using keywords related to LC & OTC medication including naturals Results: The lack of a clear clinical definition makes management of LC symptoms challenging. The prevalence of LC varies from 5–30%, affecting major organ systems & patients’ quality of life (QoL). Common symptoms include fatigue, dyspnea, persistent cough, chest pain, myalgia, anxiety, fever. While no specific treatments are approved, OTC medications can help manage symptoms & improve patients QoL. Studies indicate that paracetamol and non-steroidal anti-inflammatory drugs (NSAIDs) can help with symptoms like fever or pain lasting ≥3 months after COVID-19. Also, OTC medications and naturals, like mucolytics, antitussives and antihistamines, may benefit for selected LC patients. Promising OTC medications may eventually be incorporated into evidence-based guidelines for managing certain LC symptoms Conclusion: LC imposes a significant medical burden on patients, of treatment without guidance affecting their QoL. While no specific treatments are approved, symptomatic management approaches can provide relief. Several OTC medications effectively address mild-to-moderate LC symptoms, including those related to colds, flu, fever and pain
Fetched live from OpenAlex and de-inverted. Abstracts are not stored in this database: the inverted indexes are 8.6 GB of the frame’s 9.3 GB of text, and the host has 13 GB free.
How this classification was reachedexpand
Full frame machine prediction
Teacher imitationNot calibrated prevalence, not ground truth. Human validation pending. The Gemma side is a direct model label for every work in the frame, read from the title-only record. The Codex side is a classifier learned from the 10,348 direct Codex labels and calibrated to design-weighted sample rates; fields without enough sample support carry no Codex call. Candidate is the union of the two sides; consensus is their intersection. These outputs are machine_predicted_unvalidated and are not human labels.
Distilled classifier scores by category (both heads)
| Category | Codex | Gemma |
|---|---|---|
| Metaresearch | 0.003 | 0.012 |
| Meta-epidemiology (narrow) | 0.001 | 0.000 |
| Meta-epidemiology (broad) | 0.002 | 0.003 |
| Bibliometrics | 0.002 | 0.001 |
| Science and technology studies | 0.001 | 0.000 |
| Scholarly communication | 0.003 | 0.003 |
| Open science | 0.001 | 0.001 |
| Research integrity | 0.002 | 0.002 |
| Insufficient payload (model declined to judge) | 0.049 | 0.009 |
Machine scores (provisional)
The two teacher heads of the student model, read on this work. A score orders the frame for review; it never asserts a category, and the validation status ships verbatim with every row.
Baseline scores from an immature model (maturity gate not passed, 7 training rounds). Scores rank; they never assert a category.
score_only:v0-immature-baseline · verbatim from the scoring run: score_only means the number may rank works, and no category label ships from itClassification
machine, unvalidatedMachine predicted; a candidate call from one source (direct Gemma or distilled Codex), not a consensus.
How this classification was reached, model by model and score by score, is at the end of the page under "How this classification was reached".